Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10485075 | Value in Health | 2012 | 10 Pages |
Abstract
The introduction of PBMs that are specific to a certain disease may have the merit of sensitivity to disease-specific effects of interventions. That gain, however, is traded off to the loss of comparability of utility values and, in some cases, insensitivity to side effects and comorbidity. The use of a CS-PBM for cost-utility analysis is warranted only under strict conditions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Matthijs M. MA, BSc, Annemieke MSc, Carin A. PhD, Elly A. PhD,